Merck (MRK) stock in focus as its lung disease drug Winrevair gains FDA priority review for a label update based on Phase 3 ...

The Cardiac Centre at Al Qassimi Hospital, operated by Emirates Health Services (EHS), has become the first facility in the ...

Liquidia shipped its first FDA-approved product, Yutrepia for pulmonary hypertension in June entering market worth several ...

MORRISVILLE, N.C., June 23, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, ...

This study highlights the vital role of caregivers in supporting women living with pulmonary arterial hypertension (PAH) and underscores the need to enhance caregiver support and address unmet needs ...

What’s driving this surge? Insmed revealed that its Phase IIb trial for treprostinil palmitil inhalation powder (TPIP) in pulmonary arterial hypertension (PAH) achieved..

Shares of Insmed jumped Tuesday after the biopharmaceutical firm reported positive results from a Phase 2 trial for its treatment of pulmonary arterial hypertension.

A board certified cardiologist has shared a list of the seven most common signs and symptoms to look out for as it could mean ...

Pulmonary hypertension (PH) is a fatal pulmonary vascular disease. The standard diagnosis of PH heavily relies on an invasive technique, i.e., right heart catheterization, which leads to a delay in ...

The higher the pulmonary artery pressure, the more sensitive is the ECG. [13] Chest radiograph is inferior to ECG in detecting pulmonary hypertension.

Quick Takes Evaluation for pulmonary hypertension (PH) in patients with cancer must include either lung ventilation/perfusion scan or dual-energy computed tomography of the chest to evaluate for acute ...